nodes	percent_of_prediction	percent_of_DWPC	metapath
Sofosbuvir—ABCB1—Sorafenib—liver cancer	0.267	0.622	CbGbCtD
Sofosbuvir—ABCB1—Doxorubicin—liver cancer	0.162	0.378	CbGbCtD
Sofosbuvir—Suicide—Sorafenib—liver cancer	0.027	0.0473	CcSEcCtD
Sofosbuvir—Completed suicide—Sorafenib—liver cancer	0.0238	0.0417	CcSEcCtD
Sofosbuvir—Haemoglobin decreased—Sorafenib—liver cancer	0.0203	0.0357	CcSEcCtD
Sofosbuvir—Dyspnoea exertional—Epirubicin—liver cancer	0.0171	0.03	CcSEcCtD
Sofosbuvir—Dyspnoea exertional—Doxorubicin—liver cancer	0.0158	0.0278	CcSEcCtD
Sofosbuvir—Gastrooesophageal reflux disease—Sorafenib—liver cancer	0.0155	0.0272	CcSEcCtD
Sofosbuvir—Blood bilirubin increased—Sorafenib—liver cancer	0.0148	0.0259	CcSEcCtD
Sofosbuvir—Influenza like illness—Sorafenib—liver cancer	0.0136	0.0238	CcSEcCtD
Sofosbuvir—Dry skin—Sorafenib—liver cancer	0.00931	0.0163	CcSEcCtD
Sofosbuvir—Nasopharyngitis—Sorafenib—liver cancer	0.00908	0.0159	CcSEcCtD
Sofosbuvir—Abdominal discomfort—Sorafenib—liver cancer	0.00842	0.0148	CcSEcCtD
Sofosbuvir—Neutropenia—Sorafenib—liver cancer	0.00821	0.0144	CcSEcCtD
Sofosbuvir—Weight decreased—Sorafenib—liver cancer	0.00794	0.0139	CcSEcCtD
Sofosbuvir—Infestation NOS—Sorafenib—liver cancer	0.00783	0.0137	CcSEcCtD
Sofosbuvir—Infestation—Sorafenib—liver cancer	0.00783	0.0137	CcSEcCtD
Sofosbuvir—Hepatobiliary disease—Sorafenib—liver cancer	0.0074	0.013	CcSEcCtD
Sofosbuvir—Connective tissue disorder—Sorafenib—liver cancer	0.00691	0.0121	CcSEcCtD
Sofosbuvir—Mediastinal disorder—Sorafenib—liver cancer	0.00633	0.0111	CcSEcCtD
Sofosbuvir—Alopecia—Sorafenib—liver cancer	0.00621	0.0109	CcSEcCtD
Sofosbuvir—Malnutrition—Sorafenib—liver cancer	0.00612	0.0107	CcSEcCtD
Sofosbuvir—Muscle spasms—Sorafenib—liver cancer	0.00588	0.0103	CcSEcCtD
Sofosbuvir—Anaemia—Sorafenib—liver cancer	0.00565	0.00991	CcSEcCtD
Sofosbuvir—Blood bilirubin increased—Epirubicin—liver cancer	0.00547	0.00959	CcSEcCtD
Sofosbuvir—Cough—Sorafenib—liver cancer	0.00534	0.00936	CcSEcCtD
Sofosbuvir—Arthralgia—Sorafenib—liver cancer	0.00521	0.00913	CcSEcCtD
Sofosbuvir—Myalgia—Sorafenib—liver cancer	0.00521	0.00913	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00517	0.00907	CcSEcCtD
Sofosbuvir—Dry mouth—Sorafenib—liver cancer	0.00509	0.00893	CcSEcCtD
Sofosbuvir—Blood bilirubin increased—Doxorubicin—liver cancer	0.00506	0.00887	CcSEcCtD
Sofosbuvir—Influenza like illness—Epirubicin—liver cancer	0.00502	0.00881	CcSEcCtD
Sofosbuvir—Infection—Sorafenib—liver cancer	0.00496	0.0087	CcSEcCtD
Sofosbuvir—Nervous system disorder—Sorafenib—liver cancer	0.0049	0.00859	CcSEcCtD
Sofosbuvir—Skin disorder—Sorafenib—liver cancer	0.00485	0.0085	CcSEcCtD
Sofosbuvir—Influenza like illness—Doxorubicin—liver cancer	0.00465	0.00815	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00455	0.00798	CcSEcCtD
Sofosbuvir—Dyspnoea—Sorafenib—liver cancer	0.00445	0.00781	CcSEcCtD
Sofosbuvir—Dyspepsia—Sorafenib—liver cancer	0.00439	0.00771	CcSEcCtD
Sofosbuvir—Decreased appetite—Sorafenib—liver cancer	0.00434	0.00761	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Sorafenib—liver cancer	0.00431	0.00756	CcSEcCtD
Sofosbuvir—Fatigue—Sorafenib—liver cancer	0.0043	0.00755	CcSEcCtD
Sofosbuvir—Constipation—Sorafenib—liver cancer	0.00427	0.00749	CcSEcCtD
Sofosbuvir—Pain—Sorafenib—liver cancer	0.00427	0.00749	CcSEcCtD
Sofosbuvir—Body temperature increased—Sorafenib—liver cancer	0.00395	0.00692	CcSEcCtD
Sofosbuvir—Migraine—Epirubicin—liver cancer	0.00369	0.00648	CcSEcCtD
Sofosbuvir—Asthenia—Sorafenib—liver cancer	0.00358	0.00628	CcSEcCtD
Sofosbuvir—Pruritus—Sorafenib—liver cancer	0.00353	0.00619	CcSEcCtD
Sofosbuvir—Dry skin—Epirubicin—liver cancer	0.00344	0.00603	CcSEcCtD
Sofosbuvir—Migraine—Doxorubicin—liver cancer	0.00342	0.006	CcSEcCtD
Sofosbuvir—Diarrhoea—Sorafenib—liver cancer	0.00342	0.00599	CcSEcCtD
Sofosbuvir—Nasopharyngitis—Epirubicin—liver cancer	0.00336	0.00589	CcSEcCtD
Sofosbuvir—Dizziness—Sorafenib—liver cancer	0.0033	0.00579	CcSEcCtD
Sofosbuvir—Dry skin—Doxorubicin—liver cancer	0.00318	0.00558	CcSEcCtD
Sofosbuvir—Vomiting—Sorafenib—liver cancer	0.00317	0.00557	CcSEcCtD
Sofosbuvir—Rash—Sorafenib—liver cancer	0.00315	0.00552	CcSEcCtD
Sofosbuvir—Dermatitis—Sorafenib—liver cancer	0.00314	0.00551	CcSEcCtD
Sofosbuvir—Headache—Sorafenib—liver cancer	0.00313	0.00548	CcSEcCtD
Sofosbuvir—Nasopharyngitis—Doxorubicin—liver cancer	0.00311	0.00545	CcSEcCtD
Sofosbuvir—Pancytopenia—Epirubicin—liver cancer	0.00308	0.0054	CcSEcCtD
Sofosbuvir—Neutropenia—Epirubicin—liver cancer	0.00303	0.00532	CcSEcCtD
Sofosbuvir—Nausea—Sorafenib—liver cancer	0.00297	0.0052	CcSEcCtD
Sofosbuvir—Weight decreased—Epirubicin—liver cancer	0.00294	0.00515	CcSEcCtD
Sofosbuvir—Infestation NOS—Epirubicin—liver cancer	0.00289	0.00507	CcSEcCtD
Sofosbuvir—Infestation—Epirubicin—liver cancer	0.00289	0.00507	CcSEcCtD
Sofosbuvir—Pancytopenia—Doxorubicin—liver cancer	0.00285	0.005	CcSEcCtD
Sofosbuvir—Neutropenia—Doxorubicin—liver cancer	0.00281	0.00492	CcSEcCtD
Sofosbuvir—Hepatobiliary disease—Epirubicin—liver cancer	0.00274	0.0048	CcSEcCtD
Sofosbuvir—Weight decreased—Doxorubicin—liver cancer	0.00272	0.00476	CcSEcCtD
Sofosbuvir—Infestation—Doxorubicin—liver cancer	0.00268	0.00469	CcSEcCtD
Sofosbuvir—Infestation NOS—Doxorubicin—liver cancer	0.00268	0.00469	CcSEcCtD
Sofosbuvir—Connective tissue disorder—Epirubicin—liver cancer	0.00255	0.00448	CcSEcCtD
Sofosbuvir—Hepatobiliary disease—Doxorubicin—liver cancer	0.00253	0.00444	CcSEcCtD
Sofosbuvir—Eye disorder—Epirubicin—liver cancer	0.00243	0.00426	CcSEcCtD
Sofosbuvir—Connective tissue disorder—Doxorubicin—liver cancer	0.00236	0.00414	CcSEcCtD
Sofosbuvir—Mediastinal disorder—Epirubicin—liver cancer	0.00234	0.0041	CcSEcCtD
Sofosbuvir—Chills—Epirubicin—liver cancer	0.00233	0.00409	CcSEcCtD
Sofosbuvir—Alopecia—Epirubicin—liver cancer	0.00229	0.00402	CcSEcCtD
Sofosbuvir—Malnutrition—Epirubicin—liver cancer	0.00226	0.00396	CcSEcCtD
Sofosbuvir—Eye disorder—Doxorubicin—liver cancer	0.00225	0.00394	CcSEcCtD
Sofosbuvir—Back pain—Epirubicin—liver cancer	0.00219	0.00383	CcSEcCtD
Sofosbuvir—Muscle spasms—Epirubicin—liver cancer	0.00217	0.00381	CcSEcCtD
Sofosbuvir—Mediastinal disorder—Doxorubicin—liver cancer	0.00217	0.0038	CcSEcCtD
Sofosbuvir—Chills—Doxorubicin—liver cancer	0.00216	0.00378	CcSEcCtD
Sofosbuvir—Vision blurred—Epirubicin—liver cancer	0.00213	0.00374	CcSEcCtD
Sofosbuvir—Alopecia—Doxorubicin—liver cancer	0.00212	0.00372	CcSEcCtD
Sofosbuvir—Malnutrition—Doxorubicin—liver cancer	0.00209	0.00367	CcSEcCtD
Sofosbuvir—Anaemia—Epirubicin—liver cancer	0.00209	0.00366	CcSEcCtD
Sofosbuvir—Agitation—Epirubicin—liver cancer	0.00208	0.00364	CcSEcCtD
Sofosbuvir—Back pain—Doxorubicin—liver cancer	0.00202	0.00355	CcSEcCtD
Sofosbuvir—Muscle spasms—Doxorubicin—liver cancer	0.00201	0.00353	CcSEcCtD
Sofosbuvir—Cough—Epirubicin—liver cancer	0.00197	0.00346	CcSEcCtD
Sofosbuvir—Vision blurred—Doxorubicin—liver cancer	0.00197	0.00346	CcSEcCtD
Sofosbuvir—Anaemia—Doxorubicin—liver cancer	0.00193	0.00339	CcSEcCtD
Sofosbuvir—Chest pain—Epirubicin—liver cancer	0.00192	0.00338	CcSEcCtD
Sofosbuvir—Myalgia—Epirubicin—liver cancer	0.00192	0.00338	CcSEcCtD
Sofosbuvir—Arthralgia—Epirubicin—liver cancer	0.00192	0.00338	CcSEcCtD
Sofosbuvir—Agitation—Doxorubicin—liver cancer	0.00192	0.00337	CcSEcCtD
Sofosbuvir—Anxiety—Epirubicin—liver cancer	0.00192	0.00336	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00191	0.00335	CcSEcCtD
Sofosbuvir—Dry mouth—Epirubicin—liver cancer	0.00188	0.0033	CcSEcCtD
Sofosbuvir—Infection—Epirubicin—liver cancer	0.00183	0.00321	CcSEcCtD
Sofosbuvir—Cough—Doxorubicin—liver cancer	0.00183	0.0032	CcSEcCtD
Sofosbuvir—Nervous system disorder—Epirubicin—liver cancer	0.00181	0.00317	CcSEcCtD
Sofosbuvir—Skin disorder—Epirubicin—liver cancer	0.00179	0.00314	CcSEcCtD
Sofosbuvir—Myalgia—Doxorubicin—liver cancer	0.00178	0.00312	CcSEcCtD
Sofosbuvir—Arthralgia—Doxorubicin—liver cancer	0.00178	0.00312	CcSEcCtD
Sofosbuvir—Chest pain—Doxorubicin—liver cancer	0.00178	0.00312	CcSEcCtD
Sofosbuvir—Anxiety—Doxorubicin—liver cancer	0.00177	0.00311	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00177	0.0031	CcSEcCtD
Sofosbuvir—Dry mouth—Doxorubicin—liver cancer	0.00174	0.00305	CcSEcCtD
Sofosbuvir—Infection—Doxorubicin—liver cancer	0.0017	0.00297	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00168	0.00295	CcSEcCtD
Sofosbuvir—Nervous system disorder—Doxorubicin—liver cancer	0.00167	0.00294	CcSEcCtD
Sofosbuvir—Insomnia—Epirubicin—liver cancer	0.00167	0.00293	CcSEcCtD
Sofosbuvir—Skin disorder—Doxorubicin—liver cancer	0.00166	0.00291	CcSEcCtD
Sofosbuvir—Dyspnoea—Epirubicin—liver cancer	0.00164	0.00288	CcSEcCtD
Sofosbuvir—Dyspepsia—Epirubicin—liver cancer	0.00162	0.00285	CcSEcCtD
Sofosbuvir—Decreased appetite—Epirubicin—liver cancer	0.0016	0.00281	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Epirubicin—liver cancer	0.00159	0.00279	CcSEcCtD
Sofosbuvir—Fatigue—Epirubicin—liver cancer	0.00159	0.00279	CcSEcCtD
Sofosbuvir—Pain—Epirubicin—liver cancer	0.00158	0.00277	CcSEcCtD
Sofosbuvir—Constipation—Epirubicin—liver cancer	0.00158	0.00277	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00156	0.00273	CcSEcCtD
Sofosbuvir—Insomnia—Doxorubicin—liver cancer	0.00154	0.00271	CcSEcCtD
Sofosbuvir—Dyspnoea—Doxorubicin—liver cancer	0.00152	0.00267	CcSEcCtD
Sofosbuvir—Dyspepsia—Doxorubicin—liver cancer	0.0015	0.00264	CcSEcCtD
Sofosbuvir—Decreased appetite—Doxorubicin—liver cancer	0.00148	0.0026	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00147	0.00258	CcSEcCtD
Sofosbuvir—Fatigue—Doxorubicin—liver cancer	0.00147	0.00258	CcSEcCtD
Sofosbuvir—Constipation—Doxorubicin—liver cancer	0.00146	0.00256	CcSEcCtD
Sofosbuvir—Pain—Doxorubicin—liver cancer	0.00146	0.00256	CcSEcCtD
Sofosbuvir—Body temperature increased—Epirubicin—liver cancer	0.00146	0.00256	CcSEcCtD
Sofosbuvir—Body temperature increased—Doxorubicin—liver cancer	0.00135	0.00237	CcSEcCtD
Sofosbuvir—Asthenia—Epirubicin—liver cancer	0.00132	0.00232	CcSEcCtD
Sofosbuvir—Pruritus—Epirubicin—liver cancer	0.00131	0.00229	CcSEcCtD
Sofosbuvir—Diarrhoea—Epirubicin—liver cancer	0.00126	0.00221	CcSEcCtD
Sofosbuvir—Asthenia—Doxorubicin—liver cancer	0.00122	0.00215	CcSEcCtD
Sofosbuvir—Dizziness—Epirubicin—liver cancer	0.00122	0.00214	CcSEcCtD
Sofosbuvir—Pruritus—Doxorubicin—liver cancer	0.00121	0.00212	CcSEcCtD
Sofosbuvir—Vomiting—Epirubicin—liver cancer	0.00117	0.00206	CcSEcCtD
Sofosbuvir—Diarrhoea—Doxorubicin—liver cancer	0.00117	0.00205	CcSEcCtD
Sofosbuvir—Rash—Epirubicin—liver cancer	0.00116	0.00204	CcSEcCtD
Sofosbuvir—Dermatitis—Epirubicin—liver cancer	0.00116	0.00204	CcSEcCtD
Sofosbuvir—Headache—Epirubicin—liver cancer	0.00116	0.00203	CcSEcCtD
Sofosbuvir—Dizziness—Doxorubicin—liver cancer	0.00113	0.00198	CcSEcCtD
Sofosbuvir—Nausea—Epirubicin—liver cancer	0.0011	0.00192	CcSEcCtD
Sofosbuvir—Vomiting—Doxorubicin—liver cancer	0.00109	0.0019	CcSEcCtD
Sofosbuvir—Rash—Doxorubicin—liver cancer	0.00108	0.00189	CcSEcCtD
Sofosbuvir—Dermatitis—Doxorubicin—liver cancer	0.00108	0.00189	CcSEcCtD
Sofosbuvir—Headache—Doxorubicin—liver cancer	0.00107	0.00188	CcSEcCtD
Sofosbuvir—Nausea—Doxorubicin—liver cancer	0.00101	0.00178	CcSEcCtD
